Navigation Links
Ventas Names Chicago as Headquarters
Date:4/24/2008

Company's expectations. The Company does not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made.

The Company's actual future results and trends may differ materially depending on a variety of factors discussed in the Company's filings with the Securities and Exchange Commission. Factors that may affect the Company's plans or results include without limitation: (a) the ability and willingness of the Company's operators, tenants, borrowers, managers and other third parties, as applicable, to meet and/or perform the obligations under their various contractual arrangements with the Company; (b) the ability and willingness of Kindred Healthcare, Inc. (together with its subsidiaries, "Kindred"), Brookdale Living Communities, Inc. (together with its subsidiaries, "Brookdale") and Alterra Healthcare Corporation (together with its subsidiaries, "Alterra") to meet and/or perform their obligations to indemnify, defend and hold the Company harmless from and against various claims, litigation and liabilities under the Company's respective contractual arrangements with Kindred, Brookdale and Alterra; (c) the ability of the Company's operators, tenants, borrowers and managers, as applicable, to maintain the financial strength and liquidity necessary to satisfy their respective obligations and liabilities to third parties, including without limitation obligations under their existing credit facilities; (d) the Company's success in implementing its business strategy and the Company's ability to identify, underwrite, finance, consummate and integrate diversifying acquisitions or investments, including those in different asset types and outside the United States; (e) the nature and extent of future competition; (f) the extent of future or pending healthcare reform and regulation, including cost containment measures and changes in reimbursement policies, procedures and rates; (g) increases in the Company's cost of
'/>"/>

SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ventas Announces 2008 First Quarter Earnings Release Date and Conference Call
2. Ventas to Present at Credit Suisse 2008 Global Real Estate Conference
3. Ventas Announces Brush Departure
4. Ventas Appoints James D. Shelton and Robert D. Reed to Board
5. Ventas to Present at the Citi 2008 Global Property CEO Conference
6. Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69
7. Ventas Completes Previously Announced Sale of Common Stock
8. Ventas Enters Agreement to Sell Common Stock
9. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
10. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
11. Ventas Appoints Brush SVP - Senior Housing Development and Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... A US Airman, fresh from basic training ...eukemia patient whose life he saved by donating hi...an Air Base, Republic of Korea (PRWEB) November 21...irman whose blood donation saved her life, met for...ov. 21, 2008. , , , , ,Airman Tamarias Pope, 8th ...
(Date:11/21/2008)..., Fla. -- A Florida State University College of Me...overed an important new layer of regulation in the...r understanding of the way cancer begins. , Wang... the College of Medicine, said the findings will l...could lead to the design of new drugs that kill ca...
(Date:11/21/2008)... Nov. 21 The Generic,P...owing statement today from,GPhA President and CEO...ssion,(FTC) roundtable on "Emerging Health Care C...e fact that the FTC is conducting this roundtable ... that consumers have access to safe and,affordabl...
(Date:11/21/2008)...a., Nov. 21 New researc...er a smokeless, spitless tobacco product aimed at ...ave found that RJ Reynolds, Camel Snus - touted as...contains surprisingly high levels of nicotine. , ...st other snuff products," said Bruce Adkins of the...
Breaking Medicine News(10 mins):Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 2Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 3Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
...ave shown inhaled corticosteroids can decrease a p... now say long-term use of ICS therapy is not assoc...teroids are commonly used to treat asthmatics and ...nary disorder. Researchers say these medications a...
... thought of rickets as a disease of the past. New ...blem and prevention should start before birth and ... vitamin D supplementation.// Rickets is a childho...kening of the bones, primarily caused by lack of v...
...ave shown breast cancer patients who receive radia...n and a mastectomy may be more likely to develop c...y not be the case. Researchers from the Fox Chase ...east cancer who underwent a mastectomy, breast rec...
...kidney patients have far more to be concerned abou...ciation-sponsored study shows //people with chroni... heart disease. Doctors say the most surprising fi...ople who are in the very early stages of kidney di...
Other Medicine News:
(Date:11/20/2008)...ember 20 The Scandinavian-based dr...ced results of studies on its,lead antimicrobial ...n, DC,the studies showed that the novel lytic pe...ect, significantly better towards killing Staphylo...keted gold standard drugs. In,addition to this it...
(Date:11/19/2008).... 19 Biotech scientists increasing...y research to better understand the effects of nov...reports Genetic Engineering & Biotechnology N...guring out a new compound,s mechanism of action an...chnique, according to the November 15 issue of GE...
(Date:11/18/2008)...PRNewswire/ -- Arlington Medical Resources (AMR), ... pharmaceutical and diagnostic,imaging industries...vigen was,sold in the U.S. during the third quart...venous immune globulin (IVIG) and was launched in ...ted from the blood plasma of thousands,of donors ...
(Date:11/13/2008)...Nutritional Supplements Prior to Surgery, ARLINGT...-- Identifying,malnutrition before surgery in mass...ill significantly decrease surgical complications,...d boost patient energy levels,according to a stud...ive,Surgery(R), the official medical journal of th...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Newt Gingrich Statement on the Loss of Tony Snow 23855 1Newt Gingrich Statement on the Loss of Tony Snow 23855 2Summer Is Peak Time for Lightning Strikes 23851 1Summer Is Peak Time for Lightning Strikes 23851 2Dramatic increase in Tommy John surgery in young patients cause for concern 23847 1Dramatic increase in Tommy John surgery in young patients cause for concern 23847 2Bioheart Inc Announces Management Change 6516 1Bioheart Inc Announces Management Change 6516 2Bioheart Inc Announces Management Change 6516 3
..., May 21, 2007 - Results from phase III,clinical t...presented at the 16th Congress of the European Aca...data highlighted the,efficacy and safety profile o...tment for patients with severe refractory chronic,...ists for severe Chronic Hand,Eczema (CHE) refracto...
...INESS WIRE)--May 21, 2007 - Gilead Sciences,Inc. ...term studies,evaluating ambrisentan, an investigat... treatment of patients with pulmonary,arterial hyp...ients,who originally participated in the two pivot... study of patients who had,previously discontinued...
Other Medicine Technology:Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 2Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 3Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 4Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 5Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 6
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: